[ad_1]
British researchers are testing a self-badysis device that can revolutionize the diagnosis of cancer. The device is designed to detect cancer markers in molecules that the patient exhales with exhalation.
Scientists hope that this device will detect early and at a lower cost cancers at an early stage, when they are more likely to respond to treatment.
He says the device can save thousands of lives and millions of pounds in health care costs. The two-year trial conducted at the Edinburgh Hospital in Edinburgh has 1,500 patients, including healthy people, as well as cancer patients.
At first, it will be asked to patients suspected of having esophageal cancer to try the test. The test will then extend to cancers of the prostate, kidneys, bladder, liver and pancreas.
The participants will have to breathe at the psychologist for 10 minutes, then the aggregated molecules, called VOCs, will be sent by test to the Cambridge laboratory for badysis. The cells of the body produce a group of volatile compounds as part of normal metabolism and enter the lungs and appear in the breath.
The idea behind the test is that cancer can cause obvious changes in VOC structure. If the technology proves to be accurate and reliable, it is possible that this psychologist will become common in general surgery.
The inventor of the test, the British company Olston, is managed in collaboration with the UK Cancer Research Center. According to government statistics, about half of all cancers in England are diagnosed at a later stage.
This late diagnosis is one of the main reasons why only 12% of patients with esophageal cancer survive for 10 years.
Source link
